• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events.急性冠状动脉综合征中的抗凝和抗血小板治疗：在出血的锡拉岩礁与缺血事件的卡律布狄斯漩涡之间做出抉择。
Neth Heart J. 2018 Jun;26(6):287-288. doi: 10.1007/s12471-018-1121-5.
2
Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis?
Int J Clin Pharmacol Ther. 2009 Jan;47(1):1-10. doi: 10.5414/cpp47001.
3
Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis.接受经皮冠状动脉介入治疗的心房颤动患者的联合抗血小板和抗凝治疗：在锡拉岩礁和卡律布狄斯漩涡之间寻找出路
Ann Intern Med. 2020 Apr 7;172(7):495-496. doi: 10.7326/M20-0572. Epub 2020 Mar 17.
4
Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.口服抗凝药与抗血小板治疗对预防短暂性脑缺血发作或疑似动脉源性轻度卒中后进一步血管事件的比较
Cochrane Database Syst Rev. 2001(4):CD001342. doi: 10.1002/14651858.CD001342.
5
Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.口服抗凝药与抗血小板治疗对预防动脉源性短暂性脑缺血发作或轻度卒中后进一步血管事件的比较
Cochrane Database Syst Rev. 2006 Jul 19(3):CD001342. doi: 10.1002/14651858.CD001342.pub2.
6
Clinical evidence for oral antiplatelet therapy in acute coronary syndromes.急性冠状动脉综合征的口服抗血小板治疗的临床证据。
Lancet. 2015 Jul 18;386(9990):292-302. doi: 10.1016/S0140-6736(15)60213-6. Epub 2015 Mar 14.
7
Antiplatelet and anticoagulation therapy for acute coronary syndromes.急性冠脉综合征的抗血小板和抗凝治疗。
Circ Res. 2014 Jun 6;114(12):1929-43. doi: 10.1161/CIRCRESAHA.114.302737.
8
Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care.正在进行的以及计划开展的抗血小板治疗用于缺血性脑综合征患者急性和长期管理的试验：确立新的护理标准。
Cerebrovasc Dis. 2004;17 Suppl 3:11-6. doi: 10.1159/000075299.
9
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.在急性冠脉综合征（GEMINI-ACS-1）中，与低剂量利伐沙班加 P2Y12 抑制相比，加用阿司匹林导致临床显著出血：一项双盲、多中心、随机试验。
Lancet. 2017 May 6;389(10081):1799-1808. doi: 10.1016/S0140-6736(17)30751-1. Epub 2017 Mar 18.
10
Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis.使用抗炎药物应对缺血性心脏病中的残余风险：进退维谷。
Eur Heart J. 2021 Jul 21;42(28):2715-2719. doi: 10.1093/eurheartj/ehab450.

引用本文的文献

1
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention.不同剂量替罗非班对接受经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者的影响。
Medicine (Baltimore). 2020 Jun 5;99(23):e20402. doi: 10.1097/MD.0000000000020402.

本文引用的文献

1
Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.心房颤动围手术期抗凝治疗：电复律与消融的最新进展
Neth Heart J. 2018 Jun;26(6):352-360. doi: 10.1007/s12471-018-1119-z.
2
A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment.关于如何在口服抗血栓治疗期间处理出血事件患者的实用指南。
Neth Heart J. 2018 Jun;26(6):341-351. doi: 10.1007/s12471-018-1117-1.
3
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management.心房颤动的最佳长期抗栓治疗管理：生命周期管理
Neth Heart J. 2018 Jun;26(6):311-320. doi: 10.1007/s12471-018-1118-0.
4
Optimal treatment of patients with NSTE-ACS in the Dutch health care system.荷兰医疗保健系统中NSTE-ACS患者的最佳治疗
Neth Heart J. 2018 Jun;26(6):289-295. doi: 10.1007/s12471-018-1114-4.
5
Optimal duration of dual antiplatelet therapy for coronary artery disease.冠状动脉疾病双联抗血小板治疗的最佳持续时间。
Neth Heart J. 2018 Jun;26(6):321-333. doi: 10.1007/s12471-018-1113-5.
6
Optimal pharmacological therapy in ST-elevation myocardial infarction-a review : A review of antithrombotic therapies in STEMI.ST段抬高型心肌梗死的最佳药物治疗——综述：ST段抬高型心肌梗死抗栓治疗综述
Neth Heart J. 2018 Jun;26(6):296-310. doi: 10.1007/s12471-018-1112-6.
7
Selection of P2Y Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome.经皮冠状动脉介入治疗和/或急性冠状动脉综合征中 P2Y 抑制剂的选择。
Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):460-470. doi: 10.1016/j.pcad.2018.01.003. Epub 2018 Jan 12.
8
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.药物洗脱支架植入术后，无论患者有无急性冠脉综合征，给予3个月、6个月或12个月双联抗血小板治疗：六项随机试验和11473例患者的个体患者数据成对和网状荟萃分析
Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627.
9
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.双联抗血小板治疗时间：2016 年 ACC/AHA 指南双联抗血小板治疗时间的聚焦更新：冠心病患者双联抗血小板治疗时间的临床实践指南——美国心脏病学会/美国心脏协会工作组报告。
J Am Coll Cardiol. 2016 Sep 6;68(10):1116-39. doi: 10.1016/j.jacc.2016.03.512. Epub 2016 Mar 29.
10
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.心肌梗死后的长期抗血小板治疗：PEGASUS-TIMI 54研究的启示
Heart. 2016 May 15;102(10):783-9. doi: 10.1136/heartjnl-2015-307858. Epub 2016 Feb 8.

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events.

作者信息

de Winter R J

机构信息

Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Neth Heart J. 2018 Jun;26(6):287-288. doi: 10.1007/s12471-018-1121-5.

DOI:10.1007/s12471-018-1121-5
PMID:29797236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5968008/
Abstract
摘要